Workflow
24Q3医药持仓维持低位，恒瑞医药持仓攀升
长城证券·2024-11-08 08:25

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical industry [1][22]. Core Insights - The pharmaceutical sector has faced continuous pressure in 2024, with the Shenwan Pharmaceutical Index declining by 11.19% from January 1 to October 31, 2024, underperforming the CSI 300 Index by 24.60 percentage points [1][4]. - The Hang Seng Healthcare Index also fell by 13.66%, lagging behind the Hang Seng Index by 34.68 percentage points [1][4]. - The top five performing stocks in the A-share pharmaceutical sector include Shuangcheng Pharmaceutical (+397.74%), Xiangxue Pharmaceutical (+191.26%), Maike Audi (+144.13%), Changshan Pharmaceutical (+78.17%), and Chuaning Biological (+68.26%) [1][7]. - Conversely, the five stocks with the largest declines are Jianzhijia (-56.01%), Puli Pharmaceutical (-54.24%), Puri Eye Hospital (-54.10%), Jindike (-52.32%), and Zhifei Biological (-52.15%) [1][9]. Market Performance Analysis - The pharmaceutical sector's performance ranks 31st among 31 Shenwan first-level industries [4]. - Sub-sectors such as chemical pharmaceuticals, traditional Chinese medicine II, medical devices, pharmaceutical commerce, medical services, and biological products have experienced declines of 0.75%, 5.67%, 11.71%, 14.32%, 20.70%, and 23.28%, respectively [4][6]. Public Fund Holdings Analysis - As of Q3 2024, the pharmaceutical sector's fund holding ratio is 10.18%, a decrease of 0.61 percentage points from the previous quarter [10][11]. - The top ten stocks by fund holding ratio in the pharmaceutical sector are: 1. Heng Rui Pharmaceutical (10.83%) 2. Mindray Medical (10.34%) 3. WuXi AppTec (5.69%) 4. Aier Eye Hospital (3.59%) 5. Tigermed (3.27%) 6. United Imaging (2.72%) 7. Huatai Medical (2.55%) 8. Kelun Pharmaceutical (2.29%) 9. Kanglong Chemical (1.84%) 10. Pianzi Pharmaceutical (1.75%) [11][12]. - The stocks with the highest increase in market value in Q3 2024 include Heng Rui Pharmaceutical (+3.7 billion), Aier Eye Hospital (+2.2 billion), and Bai Jie Shen Zhou-U (+1.3 billion) [12][13].